These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Ticlopidine-induced severe agranulocytosis after the placement of coronary artery stent--a case report.
    Author: Sari R, Sevinc A, Buyukberber S.
    Journal: Angiology; 2000 Jul; 51(7):591-3. PubMed ID: 10917583.
    Abstract:
    Ticlopidine is an oral antiplatelet agent frequently utilized in the treatment of cerebrovascular disease. It is rarely associated with severe bone marrow suppression. A case of an elderly woman is reported who developed febrile agranulocytosis two months after commencing ticlopidine but who had a favorable outcome after cessation of that drug and treatment with granulocyte colony-stimulating factor (G-CSF). All patients should have regular monitoring of their blood counts during therapy with ticlopidine.
    [Abstract] [Full Text] [Related] [New Search]